Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MRE (medco research) -- Ignore unavailable to you. Want to Upgrade?

To: Early Out who wrote (92)	5/4/1998 4:11:00 PM
From: Harold V	Read Replies (1) \| Respond to of 192

John, I bring up the Yahoo service a couple of times of day and have always been mystified by their "Research" on MRE. I suspect that they keep updating the page without doing any digging. MRE has been earning over 30 cents/quarter, and if they do that or better, the company will far exceed the '98 and '99 estimates on Yahoo. Further down in the postings on this service, you'll find "Sam" and others making their predictions. MRE's adenoscine product is being utilized by more and more cardiologists for more uses. The producer of adenoscine, Fugjisawa, Inc., also has an aggressive sales force. And the income of MRE's mounting amount of cash doesn't hurt any. I nevertheless suspect that the real jump in prices with come when MRE developes various cardio-protective uses of adenosine in its various formulation. Also check the news items listed in Yahoo. Harold V